- Home
- CRBU vs VOR Comparison
CRBU vs VOR Comparison
Compare CRBU & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- VOR
- Stock Information
- Founded
- CRBU 2011
- VOR 2015
- Country
- CRBU United States
- VOR United States
- Employees
- CRBU N/A
- VOR N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- CRBU Health Care
- VOR Health Care
- Exchange
- CRBU Nasdaq
- VOR Nasdaq
- Market Cap
- CRBU 93.0M
- VOR 22.1M
- IPO Year
- CRBU 2021
- VOR 2021
- Fundamental
- Price
- CRBU $1.06
- VOR $0.20
- Analyst Decision
- CRBU Strong Buy
- VOR Buy
- Analyst Count
- CRBU 4
- VOR 6
- Target Price
- CRBU $8.50
- VOR $7.20
- AVG Volume (30 Days)
- CRBU 943.1K
- VOR 5.4M
- Earning Date
- CRBU 05-08-2025
- VOR 05-14-2025
- Dividend Yield
- CRBU N/A
- VOR N/A
- EPS Growth
- CRBU N/A
- VOR N/A
- EPS
- CRBU N/A
- VOR N/A
- Revenue
- CRBU $9,918,000.00
- VOR N/A
- Revenue This Year
- CRBU N/A
- VOR N/A
- Revenue Next Year
- CRBU $161.81
- VOR N/A
- P/E Ratio
- CRBU N/A
- VOR N/A
- Revenue Growth
- CRBU N/A
- VOR N/A
- 52 Week Low
- CRBU $0.66
- VOR $0.13
- 52 Week High
- CRBU $3.00
- VOR $1.80
- Technical
- Relative Strength Index (RSI)
- CRBU 56.92
- VOR 26.80
- Support Level
- CRBU $0.98
- VOR $0.17
- Resistance Level
- CRBU $1.21
- VOR $0.20
- Average True Range (ATR)
- CRBU 0.10
- VOR 0.03
- MACD
- CRBU 0.02
- VOR 0.02
- Stochastic Oscillator
- CRBU 65.99
- VOR 38.76
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.